Sort   by:  
 Page size 
UnknownEverolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial.
Not available
S-EPMC5037621 | biostudies-literature
Unknown[Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: Time matters].
Not available
S-EPMC10073578 | biostudies-literature
UnknownImpact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: time matters.
Not available
S-EPMC10074179 | biostudies-literature
UnknownValidation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry.
Not available
S-EPMC9862219 | biostudies-literature
UnknownCharacterisation of the blood RNA host response underpinning severity in COVID-19 patients.
Not available
S-EPMC9288817 | biostudies-literature
UnknownIn-hospital care, complications, and 4-month mortality following a hip or proximal femur fracture: the Spanish registry of osteoporotic femur fractures prospective cohort study.
Not available
S-EPMC6153683 | biostudies-literature
UnknownImpact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.
Not available
S-EPMC11882944 | biostudies-literature
UnknownAlpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
Not available
S-EPMC8380059 | biostudies-literature
UnknownA multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity.
Not available
S-EPMC8861187 | biostudies-literature
UnknownEffects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Not available
S-EPMC8244648 | biostudies-literature
Sort   by:  
 Page size